News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
PERCEPTIVE ADVISORS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 8.9% stake in Bellerophon Therapeutics, Inc. |
| 03/07/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.5% stake in Reata Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.5% stake in Arcellx, Inc. |
| 02/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 9.7% stake in Veru Inc. |
| 02/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.9% stake in Cincor Pharma Inc. |
| 02/14/2023 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.6% stake in Larimar Therapeutics, Inc. |
| 11/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/23/2022 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7% stake in Relmada Therapeutics, Inc. |
| 07/18/2022 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5% stake in Inhibrx, Inc. |
| 06/21/2022 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.1% stake in Amylyx Pharmaceuticals, Inc. |
| 03/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/06/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/22/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 12.4% stake in IsoPlexis Corporation |
| 09/17/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 9.9% stake in Hancock Jaffe Laboratories, Inc. |
| 05/03/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 13.9% stake in Rain Therapeutics Inc. |
| 03/26/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6% stake in Research Alliance Corp. II |
| 03/22/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.2% stake in Forte Biosciences, Inc. |
| 03/18/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 8.6% stake in Prometheus Biosciences, Inc. |
| 02/16/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.8% stake in SC Health Corp. |
| 02/16/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7.3% stake in C4 Thereapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7.7% stake in Oncorus, Inc. |
| 02/16/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.7% stake in Outset Medical, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.5% stake in AnaptysBio, Inc. |
| 01/27/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.8% stake in SCYNEXIS, Inc. |
| 12/14/2020 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.4% stake in RAPT Therapeutics, Inc. |
| 10/28/2020 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5% stake in IVERIC bio, Inc. |
| 10/28/2020 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 7% stake in BCLS Acquisition Corp. |
| 10/07/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/01/2020 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 5.8% stake in Protara Therapeutics, Inc. |
| 06/11/2020 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 14% stake in Menlo Therapeutics, Inc. |
|
|
|